Low Dose Beta Blockade in Acute Stroke "BEST"

Completed

Phase 3 Results

Results

Deaths were more common among the patients taking beta blockers. The proportion of patients living at home at 6 months did not differ significantly between treatment groups. Neurological recovery and functional outcome were also similar.